Medicaid Drug Coverage
The prescription drug benefit in Texas Medicaid is heavily influenced by pharmaceutical companies, causing higher costs, physician administrative burdens, and delays in access to necessary medications. Allowing managed care organizations to fully manage the Medicaid PDL would improve patient care, save taxpayer dollars, and modernize the Medicaid system.
This implementation has already been delayed 10 years due to pharmaceutical lobbying, and it is crucial that Texas prioritizes the needs of its citizens and the effectiveness of its health care system over protecting pharmaceutical profits. Further delays will harm health outcomes, access to prescription drugs, and efforts to improve patient outcomes, as well as significantly increase Medicaid costs.
States with managed care coordination of drug coverage save 21% compared to states that do not use managed care.
